Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma

Clinical trial NCT03631043 · COMPLETED

Trial details

NCT number: NCT03631043
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Smoldering Plasma Cell Myeloma

Start date: 2018-12-21
Primary completion: 2025-12-10
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.